Autolus Therapeutics plc Annual Depreciation in USD from 2016 to 2023

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Autolus Therapeutics plc quarterly/annual Depreciation history and growth rate from 2016 to 2023.
  • Autolus Therapeutics plc Depreciation for the quarter ending September 30, 2024 was $1.9M, a 35.7% increase year-over-year.
  • Autolus Therapeutics plc Depreciation for the twelve months ending September 30, 2024 was $7.4M.
  • Autolus Therapeutics plc annual Depreciation for 2023 was $6.6M, a 9.59% decline from 2022.
  • Autolus Therapeutics plc annual Depreciation for 2022 was $7.3M, a 15.1% decline from 2021.
  • Autolus Therapeutics plc annual Depreciation for 2021 was $8.6M, a 50.9% increase from 2020.
Depreciation, Trailing 12 Months (USD)
Depreciation, Annual (USD)
Depreciation, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $6.6M -$700K -9.59% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-21
2022 $7.3M -$1.3M -15.1% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-21
2021 $8.6M +$2.9M +50.9% Jan 1, 2021 Dec 31, 2021 10-K 2024-03-21
2020 $5.7M +$1.1M +23.9% Jan 1, 2020 Dec 31, 2020 20-F 2023-03-07
2019 $4.6M +$2.89M +169% Jan 1, 2019 Dec 31, 2019 20-F 2022-03-10
2018 $1.71M +$700K +69.4% Oct 1, 2017 Sep 30, 2018 20-F 2020-03-03
2017 $1.01M +$531K +111% Oct 1, 2016 Sep 30, 2017 20-F 2020-03-03
2016 $478K Oct 1, 2015 Sep 30, 2016 20-F 2019-02-25
* An asterisk sign (*) next to the value indicates that the value is likely invalid.